1.
J Transl Int Med
; 5(2): 79-89, 2017 Jun.
Article
in English
| MEDLINE
| ID: mdl-28721339
ABSTRACT
The role of GLP-1 agonists in the treatment of type 2 diabetes have been shown to be viable options for add-on therapy in diabetic patients, as well as potential monotherapy options. With six available GLP-1 agents, and new combination products in the pipeline, they are a promising drug class for type 2 diabetic patients, especially due to their extended dosing interval and potential weight loss benefits.